Antiestrogenic compounds inhibit estrogen induced expressions of basic fibroblast growth factor and its mRNA in well-differentiated endometrial cancer cells.
Gagliardi
A R
AR
Collins
D C
DC
D002454:Cell Differentiation / Q000187:drug effects; D016889:Endometrial Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D005260:Female; D016222:Fibroblast Growth Factor 2 / Q000096:biosynthesis* / Q000235:genetics; D006801:Humans; D012333:RNA, Messenger / Q000096:biosynthesis*
D004965:Estrogen Antagonists; D012333:RNA, Messenger; D016222:Fibroblast Growth Factor 2